莫西沙星治疗非淋菌性尿道(宫颈)炎临床观察  

Clinical Efficacy of Moxifloxacin in Treating Nongonococcal Urethritis/Cervicitis

作　　者：王恂[1] 曾跃斌[1] 许金华[1] 

机构地区：[1]广东省汕头市汕头大学医学院第二附属医院皮肤科,515041

出　　处：《中华全科医学》2009年第1期9-10,共2页Chinese Journal of General Practice

摘　　要：目的观察口服盐酸莫西沙星治疗非淋菌性尿道(宫颈)炎的临床疗效及不良反应。方法将120例非淋菌性尿道(宫颈)炎患者随机分为两组,治疗组60例采用盐酸莫西沙星口服,400mg/次,1次/d,连续12d;对照组60例采用克拉霉素缓释片口服,500mg/次,1次/d,连续12d,观察比较两组的疗效。结果治疗组和对照组总有效率分别为81.7%和65.0%,两组疗效比较差异有统计学意义(P<0.05),且无明显不良反应。结论盐酸莫西沙星治疗非淋菌性尿道(宫颈)炎疗效好且安全性高。Objective To evaluate the clinical efficacy and toxicity of Moxifloxaein in the treatment of nongonoeoeeal urethritis/eervieitis. Methods 120 patients with nongonoeoeeal urethritis/eervieitis were divided into two groups. The treatment group （60 eases） was treated with Moxifloxaein 400 mg daily for 12 days;while the control group（60 eases） was treated with Clarithromycin 500rag daily for 12 days. Results The total effective rate of treatment group and control group were 81.7% and 65.0% respeetively. There was significance difference between the two groups （ P 〈 0.05 ）. And all adverse events were mild and reversible. Conclusion Moxifloxaein is effective and safe in treating nongonoeoeeal urethritis/eervieitis.

关 键 词：尿道炎 宫颈炎 莫西沙星 

分 类 号：R695[医药卫生—泌尿科学]